410 related articles for article (PubMed ID: 11940547)
1. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
Tanne D; Kasner SE; Demchuk AM; Koren-Morag N; Hanson S; Grond M; Levine SR
Circulation; 2002 Apr; 105(14):1679-85. PubMed ID: 11940547
[TBL] [Abstract][Full Text] [Related]
2. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume.
Selim M; Fink JN; Kumar S; Caplan LR; Horkan C; Chen Y; Linfante I; Schlaug G
Stroke; 2002 Aug; 33(8):2047-52. PubMed ID: 12154261
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II).
Larrue V; von Kummer R R; Müller A; Bluhmki E
Stroke; 2001 Feb; 32(2):438-41. PubMed ID: 11157179
[TBL] [Abstract][Full Text] [Related]
4. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator.
Cocho D; Borrell M; Martí-Fàbregas J; Montaner J; Castellanos M; Bravo Y; Molina-Porcel L; Belvís R; Díaz-Manera JA; Martínez-Domeño A; Martínez-Lage M; Millán M; Fontcuberta J; Martí-Vilalta JL
Stroke; 2006 Apr; 37(4):996-9. PubMed ID: 16497981
[TBL] [Abstract][Full Text] [Related]
6. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
7. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
8. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
Hsu PJ; Chen CH; Yeh SJ; Tsai LK; Tang SC; Jeng JS
Cerebrovasc Dis; 2016; 42(1-2):117-21. PubMed ID: 27088493
[TBL] [Abstract][Full Text] [Related]
9. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
10. Intracerebral hemorrhage following intravenous thrombolysis in Thai patients with acute ischemic stroke.
Dharmasaroja PA; Muengtaweepongsa S; Pattaraarchachai J; Dharmasaroja P
J Clin Neurosci; 2012 Jun; 19(6):799-803. PubMed ID: 22472785
[TBL] [Abstract][Full Text] [Related]
11. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
12. Protocol violations in community-based rTPA stroke treatment are associated with symptomatic intracerebral hemorrhage.
Lopez-Yunez AM; Bruno A; Williams LS; Yilmaz E; Zurrú C; Biller J
Stroke; 2001 Jan; 32(1):12-6. PubMed ID: 11136907
[TBL] [Abstract][Full Text] [Related]
13. Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset?
Kent DM; Ruthazer R; Selker HP
Stroke; 2003 Feb; 34(2):464-7. PubMed ID: 12574561
[TBL] [Abstract][Full Text] [Related]
14. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator.
Derex L; Hermier M; Adeleine P; Pialat JB; Wiart M; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P; Nighoghossian N
J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):70-5. PubMed ID: 15607998
[TBL] [Abstract][Full Text] [Related]
15. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
Seet RC; Rabinstein AA
Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
Vandelli L; Marietta M; Gambini M; Cavazzuti M; Trenti T; Cenci MA; Casoni F; Bigliardi G; Pentore R; Nichelli P; Zini A
J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721
[TBL] [Abstract][Full Text] [Related]
18. [Multi-mode MRI-based intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) reduces hemorrhagic transformation in ischemic stroke patients].
Lin YH; Lou M; Zhu RY; Yan YQ; Zhen ZC; Ding MP
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 41(6):665-71. PubMed ID: 23239659
[TBL] [Abstract][Full Text] [Related]
19. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
20. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke.
Demchuk AM; Morgenstern LB; Krieger DW; Linda Chi T; Hu W; Wein TH; Hardy RJ; Grotta JC; Buchan AM
Stroke; 1999 Jan; 30(1):34-9. PubMed ID: 9880385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
